DVT vs VNM (2025)
KEY RATIOS
ROE (%)
DVT
—
VNM
27.3
ROA (%)
DVT
—
VNM
17.66
Gross Margin (%)
DVT
—
VNM
41.13
Net Margin (%)
DVT
—
VNM
14.77
Debt/Equity
DVT
—
VNM
0.55
Equity Multiplier
DVT
—
VNM
1.55
Balance Sheet
| Item | DVT | VNM |
|---|---|---|
| Current Assets | — | 36,261 |
| Non-Current Assets | — | 17,051 |
| Fixed Assets | — | 12,649 |
| Total Assets | — | 53,312 |
| Total Liabilities | — | 18,829 |
| Current Liabilities | — | 18,520 |
| Non-Current Liabilities | — | 309.1 |
| Owner's Equity | — | 34,483 |
Income Statement
| Item | DVT | VNM |
|---|---|---|
| Revenue | — | 63,724 |
| Profit Attr. to Parent | — | 9,410.2 |
| Cost of Goods Sold | — | -37,436 |
| Gross Profit | — | 26,209 |
| Selling Expenses | — | -13,642 |
| G&A Expenses | — | -1,904.1 |
| Operating Profit | — | 11,660 |
| Profit Before Tax | — | 11,650 |
| Net Profit After Tax | — | 9,413.6 |
Cash Flow
| Item | DVT | VNM |
|---|---|---|
| Depreciation | — | 2,116.2 |
| Interest Paid | — | -311.5 |
| Tax Paid | — | -1,536.1 |
| Operating Cash Flow | — | 8,668.1 |
| Capex | — | -1,762.0 |
| Investing Cash Flow | — | 1,976.1 |
| Proceeds From Borrowings | — | 19,499 |
| Repayment Of Borrowings | — | -19,323 |
| Dividends Paid | — | -11,264 |
| Financing Cash Flow | — | -11,082 |
| Net Change in Cash | — | -437.7 |
| Ending Cash Balance | — | 1,794.9 |